Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram …

JH Jeong, WM Bahk, YS Woo, KU Lee… - Neuropsychiatric …, 2015 - Taylor & Francis
Objectives The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure®) versus branded escitalopram …

[PDF][PDF] Efficacy and safety of generic escitalopram (lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded …

JH Jeong, WM Bahk, YS Woo… - Neuropsychiatric …, 2015 - pdfs.semanticscholar.org
Objectives: The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure®) versus branded escitalopram …

Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram …

J Jong-Hyun, WM Bahk, YS Woo… - Neuropsychiatric …, 2015 - search.proquest.com
Objectives: The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure®) versus branded escitalopram …

[HTML][HTML] Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded …

JH Jeong, WM Bahk, YS Woo, KU Lee… - Neuropsychiatric …, 2015 - ncbi.nlm.nih.gov
Objectives The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure®) versus branded escitalopram …

Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram …

JH Jeong, WM Bahk, YS Woo, KU Lee… - Neuropsychiatric …, 2015 - dovepress.com
Objectives: The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure®) versus branded escitalopram …

[PDF][PDF] Efficacy and safety of generic escitalopram (lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded …

JH Jeong, WM Bahk, YS Woo, KU Lee… - Neuropsychiatric …, 2015 - academia.edu
Objectives: The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure®) versus branded escitalopram …

[PDF][PDF] Efficacy and safety of generic escitalopram (lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded …

JH Jeong, WM Bahk, YS Woo, KU Lee… - Neuropsychiatric …, 2015 - scienceopen.com
Objectives: The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure®) versus branded escitalopram …

Efficacy and safety of generic escitalopram (Lexacure [R]) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram …

JH Jeong, WM Bahk, YS Woo, KU Lee… - Neuropsychiatric …, 2015 - go.gale.com
Objectives: The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure [R]) versus branded …

Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: A 6-week multicenter, randomized, rater-blinded, escitalopram …

JH Jeong, WM Bahk, YS Woo, KU Lee… - Neuropsychiatric …, 2015 - cuk.elsevierpure.com
Objectives: The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure®) versus branded escitalopram …

Efficacy and safety of generic escitalopram (Lexacure (®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram …

JH Jeong, WM Bahk, YS Woo… - Neuropsychiatric …, 2015 - pubmed.ncbi.nlm.nih.gov
Objectives The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure (®)) versus branded …